Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:

Latest Company News

itim targets the margin gap in UK retail

A new series from ITIM examining how structured retail excellence and applied technology can help close the UK retail margin gap.

Meridian Holdings begins trading as MRDN following rebrand from Golden Matrix Group

Meridian Holdings Inc. commenced trading under its new Nasdaq ticker, MRDN, on March 3, 2026, following a 1-for-12 reverse stock split and name change from Golden Matrix Group, Inc..

7 Top Investment Trust ISA Opportunities 2026

In this article, we’ve handpicked a mix of top investment trusts managed by Manulife CQS Investment Management, Ruffer LLP, Cheyne Capital, Goodhart Partners LLP, JPMorgan Asset Management and Fidelity.

FTSE 100 Drops Sharply as Middle East Conflict and Rising Energy Prices Hit Markets

FTSE 100 drops sharply as oil prices surge on geopolitical tensions, hitting banks and travel stocks while energy shares provide support.

Helium’s expanding role across healthcare, technology and space

Helium’s essential role in healthcare, semiconductors and space activity connects it to several long term industrial growth themes.

Graphite’s Strategic Importance Sharpens

Graphite demand is rising with battery production, while supply concentration and policy shifts are reshaping its investment profile.

    Search

    Search